Tenofovir alafenamide plus dolutegravir as a switch strategy in HIV-infected patients: a pilot randomized controlled trial
Article in DARU Journal of Pharmaceutical Sciences (August 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Adherence to antiretroviral therapy and viral suppression: Analysis of three periods between 2011 and 2017 at an HIV-AIDS center, Brazil
Article in Frontiers in Pharmacology (March 2023)
Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature
Article in Expert Review of Anti-infective Therapy (November 2022)